| Literature DB >> 22083088 |
Abstract
A recent report has identified uroguanylin as an endocrine signal that exerts a physiological role in energy homeostasis, adding another factor to the gut–brain axis. From a clinical point of view, several observations highlight the uroguanylin–guanylyl cyclase C pathway as a potential therapeutic target for the development of antiobesity drugs.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22083088 DOI: 10.1038/nrendo.2011.206
Source DB: PubMed Journal: Nat Rev Endocrinol ISSN: 1759-5029 Impact factor: 43.330